Tag: liquid biopsy
Natera wins FDA breakthrough tag for a 12-cancer blood test
Natera's cell-free DNA screening assay earned FDA Breakthrough Device designation after the agency reviewed data across 12 cancer types.
FDA advisers weigh the first blood test for many cancers
An FDA advisory panel voted on whether to recommend Galleri, the first multi-cancer blood screening test to reach that stage.
PANXEON reads three signals to catch pancreatic cancer sooner
An AI-scored liquid biopsy from City of Hope caught stage 1 and 2 pancreatic cancer 87% of the time in…
Craif’s $33M Series D funds AI urine test for pancreatic cancer
Japanese bio-AI startup Craif banks $33M to push its urine-based pancreatic cancer test toward US launch.
Tempus AI acquires Personalis for $1.5B in precision medicine play
Tempus AI adds Personalis' liquid biopsy and tumor sequencing capabilities in a $1.5 billion acquisition.